CB2 receptor ligands for the treatment of psychiatric disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9486419
SERIAL NO

14785086

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides cannabinoid type 2 (CB2) receptor inverse agonists for treating or ameliorating psychiatric disorders. The present invention further provides pharmaceutical compositions comprising 4′-O-methylhonokiol for treating Attention Deficit Hyperactivity Disorder (ADHD) and Tourette's syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTDKIRYAT HAMADA P O BOX 3 ARIEL 4070000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anavi-Goffer, Sharon Ashdod, IL 13 96
Gertsch, Juerg Schaffhausen, CH 6 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 8, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00